Neither of these mutations was sufficient to initiate gliomas alone, but when each was expressed in combination with homozygous loss of Pten and Ink4a, both mutations were able to produce high-grade gliomas with a short latency. The gene discussed is PTEN; the disease is central nervous system cancer.